Advanced Medical Solutions Group (LON:AMS) Stock Price Passes Above Two Hundred Day Moving Average After Insider Selling

Key Points

• Advanced Medical Solutions Group plc's stock price has surpassed its 200-day moving average following an insider purchase, with shares currently trading at GBX 211.50.
• Multiple firms, including Deutsche Bank and Berenberg Bank, have reaffirmed a "buy" rating on the stock, with target prices ranging from GBX 246 to GBX 300.
• The company reported GBX 5.77 earnings per share for the last quarter, showcasing a net margin of 8.49% and an expected annual EPS of 9.82.

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) shares crossed above its 200-day moving average during trading on Thursday after an insider bought additional shares in the company. The stock has a 200-day moving average of GBX 203.36 ($2.71) and traded as high as GBX 222 ($2.96). Advanced Medical Solutions Group shares last traded at GBX 211.50 ($2.82), with a volume of 1,392,048 shares.

Analyst Ratings Changes

Several research firms have issued reports on AMS. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 275 price target on shares of Advanced Medical Solutions Group in a research report on Wednesday, July 16th. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 300 target price on shares of Advanced Medical Solutions Group in a report on Wednesday, September 17th. Finally, Peel Hunt reaffirmed a "buy" rating and issued a GBX 246 target price on shares of Advanced Medical Solutions Group in a report on Wednesday, September 17th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of GBX 273.67.

Advanced Medical Solutions Group Price Performance

The company has a market capitalization of £457.12 million, a P/E ratio of 6,507.69, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company's 50-day moving average price is GBX 206.28 and its two-hundred day moving average price is GBX 203.36. The company has a debt-to-equity ratio of 37.01, a current ratio of 8.39 and a quick ratio of 4.58.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last issued its quarterly earnings data on Wednesday, September 17th. The company reported GBX 5.77 earnings per share for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. As a group, sell-side analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.